Clear Creek Financial Management’s Novo Nordisk NVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.12M Buy
30,581
+14,443
+89% +$684K 0.09% 237
2025
Q4
$821K Buy
+16,138
New +$825K 0.07% 274
2025
Q1
Sell
-5,234
Closed -$450K 539
2024
Q4
$450K Buy
+5,234
New +$566K 0.05% 313

Other funds holding NVO

Clear Creek Financial Management's NVO Position: Q1 2026 in Review

Clear Creek Financial Management increased its Novo Nordisk (NVO) stake by 89% in Q1 2026, buying an estimated $684K and bringing the position to 30,581 shares worth $1.12M. The position accounts for 0.09% of the portfolio, ranked #237.

Clear Creek Financial Management first reported a position in NVO in Q4 2024 and has held it in 3 quarters since. 1,273 funds tracked by Wall St. Rank hold NVO as of Q1 2026.

  • Clear Creek Financial Management held 30,581 shares of Novo Nordisk worth $1.12M as of Q1 2026.
  • Clear Creek Financial Management bought 14,443 Novo Nordisk shares in Q1 2026, an estimated $684K.
  • Novo Nordisk made up 0.09% of Clear Creek Financial Management's portfolio in Q1 2026, its #237 holding.
  • Clear Creek Financial Management first reported a position in Novo Nordisk in Q4 2024 and has held it in 3 quarters since.
  • 1,273 funds tracked by Wall St. Rank held Novo Nordisk as of Q1 2026.

Based on Clear Creek Financial Management's 13F filing for Q1 2026, filed 23 Apr 2026.